1-4 of 4
Peter Paschka, M.D.
Close
Sort by
Journal Articles

Analysis of the ETS Family Member Genes ERG, ETS2, ETS1 and FLI1 in Acute Myeloid Leukemia (AML) Patients with Normal Cytogenetics: Expression Levels and Impact On Clinical Outcome. A Study of the AMLSG.

Verena I. Gaidzik, M.D., Cailian Wang, M.D., Richard F. Schlenk, M.D., Lars Bullinger, M.D., Peter Paschka, M.D., Frank G. Rücker, M.D., Andrea Corbacioglu, Ph.D., Karina Eiwen, Jürgen Krauter, M.D., Brigitte Schlegelberger, MD, Arnold Ganser, M.D., Manuela Zucknick, Ph.D., Axel Benner, M.Sc., Hartmut Döhner, M.D., Konstanze Döhner, M.D.
Journal: Blood
Blood (2009) 114 (22): 1600.
https://doi.org/10.1182/blood.V114.22.1600.1600
Published: 2009
Journal Articles

Type and Number of Secondary Molecular Lesions Improve Outcome Prediction in Acute Myeloid Leukemia (AML) with inv(16) or t(16;16): A Study of the German-Austrian AML Study Group (AMLSG).

Peter Paschka, M.D., Juan Du, M.D., Richard F. Schlenk, M.D., Verena I. Gaidzik, M.D., Lars Bullinger, M.D., Andrea Corbacioglu, Ph.D., Manuela Zucknick, Ph.D., Axel Benner, M.Sc., Frank Stegelmann, M.D., Daniela Späth, Sabine Kayser, M.D., Brigitte Schlegelberger, M.D., Jürgen Krauter, M.D., Arnold Ganser, M.D., Hartmut Döhner, M.D., Konstanze Döhner, M.D.
Journal: Blood
Blood (2009) 114 (22): 824.
https://doi.org/10.1182/blood.V114.22.824.824
Published: 2009
Journal Articles

Mutations in the Fms-Related Tyrosine Kinase 3 (FLT3) Gene Independently Predict Poor Outcome in Acute Myeloid Leukemia (AML) with t(8;21): A Study of the German-Austrian AML Study Group (AMLSG).

Peter Paschka, M.D., Juan Du, M.D., Richard F. Schlenk, M.D., Lars Bullinger, M.D., Verena I. Gaidzik, M.D., Andrea Corbacioglu, Ph.D., Axel Benner, M.Sc., Manuela Zucknick, Ph.D., Frank Stegelmann, M.D., Daniela Späth, Sabine Kayser, M.D., Brigitte Schlegelberger, MD, Juergen Krauter, M.D., Arnold Ganser, M.D., Hartmut Döhner, Konstanze Döhner
Journal: Blood
Blood (2009) 114 (22): 825.
https://doi.org/10.1182/blood.V114.22.825.825
Published: 2009
Journal Articles

Bortezomib-Induced Down-Regulation of KIT Is Mediated by Inhibition of Sp1 and NF- k B in AML1/ETO-Positive Cells.

Shujun Liu, PhD, Jiuxia Pang, Jianhua Yu, Ph.D., Zhongfa Liu, Ph.D., Lenguyen Huynh, Jessica Kearney, Peter Paschka, M.D., Rebecca B. Klisovic, M.D., Robert Baiocchi, M.D., William Blum, M.D., Danilo Perrotti, Ph.D., Guido Marcucci, M.D.
Journal: Blood
Blood (2006) 108 (11): 4211.
https://doi.org/10.1182/blood.V108.11.4211.4211
Published: 2006